CD8A and melanoma: To determine if CD4+ and/or CD8+ T cells become cytotoxic, healthy donor PBMC were depleted for CD4+, CD8+, or CD4+ plus CD8+ cells and subsequently tested for cytotoxic activity in the presence of BiTE and PDL1+ C8161 human melanoma cells.